Shukra Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 524632 | NSE: | Pharmaceuticals & Drugs | Small Cap

Shukra Pharma Share Price

195.65 3.80 1.98%
as on 15-Jan'25 16:59

DeciZen - make an informed investing decision on Shukra Pharma

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Shukra Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
58.21
Market Cap:
840.1 Cr.
52-wk low:
30.8
52-wk high:
191.9

Is Shukra Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Shukra Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shukra Pharmaceuticals Ltd is a below average quality company.

2. Is Shukra Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Shukra Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Shukra Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shukra Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Shukra Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shukra Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 1.8%2.4%7.4%5.9%3.6%0.8%0.5%5.8%18.9%44.2%-
Value Creation
Index
-0.9-0.8-0.5-0.6-0.7-1.0-1.0-0.60.42.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.64.85.15.35.711.911.220.558.874.639
Sales YoY Gr.-87.2%6.4%3.9%6%109.4%-5.5%83%187.1%26.8%-
Adj EPS -0.10.20.20.20.2-00.10.314.23.3
YoY Gr.-NA0%5.9%-16.7%-106.7%NA400%304%318.8%-
BVPS (₹) 4.64.74.855.15.15.25.416.213.212.4
Adj Net
Profit
-0.20.50.50.50.500.10.84.418.514
Cash Flow from Ops. -22.7-0.30.80.31.20.583.2-5.2-
Debt/CF from Ops. -0.60-0.14.323.46.518.20.41.6-0.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 45.3%67.5%88.1%26.8%
Adj EPS NA95%339%318.8%
BVPS12.3%20.9%36.5%-18.5%
Share Price 118.2% 134.5% 271.4% 474.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-1.13.63.53.63-0.20.94.721.244.725.8
Op. Profit
Mgn %
-9.624.528.530.229.11312.914.19.12640.1
Net Profit
Mgn %
-610.49.89.98.2-0.31.23.77.524.937.5
Debt to
Equity
0.1000.20.40.50.60.20.20.10
Working Cap
Days
879392379467526334487277201233357
Cash Conv.
Cycle
165756431403913254-910244

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 25.80%

Sales growth is growing at healthy rate in last 3 years 88.13%

Net Profit is growing at healthy rate in last 3 years 338.99%

Sales growth is good in last 4 quarters at 120.78%

No data to display

Latest Financials - Shukra Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 3.3 -
TTM Sales (₹ Cr.) 38.5 -
BVPS (₹.) 12.4 -
Reserves (₹ Cr.) 48 -
P/BV 15.48 -
PE 58.21 -
From the Market
52 Week Low / High (₹) 30.79 / 191.85
All Time Low / High (₹) 0.02 / 188.10
Market Cap (₹ Cr.) 840
Equity (₹ Cr.) 43.8
Face Value (₹) 10
Industry PE 43.6

Management X-Ray of Shukra Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Shukra Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales355561211205975
Operating Expenses 344441010185355
Manufacturing Costs0000022000
Material Costs1211133104544
Employee Cost 1111244545
Other Costs 0111111346
Operating Profit 01122213519
Operating Profit Margin (%) -9.6%24.5%28.5%30.2%29.1%13.0%12.9%14.1%9.1%26.0%
Other Income 1000000013
Interest 0000000000
Depreciation 1001111222
Exceptional Items 0-100000000
Profit Before Tax 00111001420
Tax 0010000001
Profit After Tax 00110001419
PAT Margin (%) 5.1%2.5%9.8%9.8%8.2%0.3%1.7%3.7%7.5%24.9%
Adjusted EPS (₹)0.00.00.20.20.20.00.10.32.84.2
Dividend Payout Ratio (%)0%0%16%15%17%0%0%10%4%6%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 14141515151516162558
Share Capital 22222222411
Reserves 12131313141414152147
Minority Interest0000000000
Debt10046810343
Long Term Debt10046810343
Short Term Debt0000000000
Trade Payables11123659347
Others Liabilities 233444571210
Total Liabilities 18171924283436357578

Fixed Assets

Gross Block20202126293234354041
Accumulated Depreciation10111112131416181921
Net Fixed Assets10101014161718182020
CWIP 2222222222
Investments 0000000000
Inventories1000012432
Trade Receivables1123581073025
Cash Equivalents 12100010410
Others Assets434555441619
Total Assets 18171924283436357578

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -230101183-5
PBT 30111001420
Adjustment 0001121222
Changes in Working Capital -42-1-1-1-1-15-3-26
Tax Paid 000000000-1
Cash Flow From Investing Activity 10-1-5-2-3-2-2-4-1
Capex 10-1-5-2-3-2-2-4-2
Net Investments 0000000000
Others 0000000001
Cash Flow From Financing Activity 1-103222-7512
Net Proceeds from Shares 00000000514
Net Proceeds from Borrowing 0000002-61-1
Interest Paid 0000000000
Dividend Paid 0000000000
Others 1-104220000
Net Cash Flow 01-10000046
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)0.940.853.513.553.040.231.214.721.1644.7
ROCE (%)1.832.47.415.943.620.770.545.7918.8544.24
Asset Turnover Ratio0.140.270.280.270.250.440.320.581.070.98
PAT to CFO Conversion(x)N/AN/A01N/AN/AN/A80.75-0.26
Working Capital Days
Receivable Days7455121171228177289153117134
Inventory Days172672715112250502213
Payable Days25597245526872563762246170168

Shukra Pharmaceuticals Ltd Stock News

Shukra Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Shukra Pharma on 15-Jan-2025 16:59 is ₹195.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Jan-2025 16:59 the market cap of Shukra Pharma stood at ₹840.1.
The latest P/E ratio of Shukra Pharma as of 15-Jan-2025 16:59 is 58.21.
The latest P/B ratio of Shukra Pharma as of 15-Jan-2025 16:59 is 15.48.
The 52-week high of Shukra Pharma is ₹191.8 and the 52-week low is ₹30.79.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shukra Pharma is ₹38.51 ( Cr.) .

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.

The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its stakeholders including customers, suppliers, employees and other interest groups by large. Shukra stands for uncompromising quality and efficiency to deliver proven solutions delivered by passionate and motivated team of individuals.

The company boasts fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. Along with internationally accredited facilities it invests in people.

The company has embarked upon its ambitious journey in the field of Pharamaceutical (date of inception) with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Since then, there was no looking back, within a short span of (years) the company has come a long way in making its mark in the sector.

The company has now developed an internationally accredited Laboratory in Ahmedabad where each product and solutions are developed under stringent quality processes.

Business area of the company

The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.